Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
61.34
-1.96 (-3.10%)
At close: Aug 20, 2026, 4:00 PM EDT
61.20
-0.14 (-0.23%)
Pre-market: Aug 21, 2026, 7:16 AM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $9.13 billion as of August 21, 2026. Its market cap has increased by 121.58% in one year.
Market Cap
9.13B
Enterprise Value
7.76B
1-Year Change
121.58%
Ranking
Category
Stock Price
$61.34
ChartMarket Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $9.13B, an increase of 561.45%. That is a compound annual growth rate of 35.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 9.13B | 51.12% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 10.18B |
| Apogee Therapeutics | 10.16B |
| Kymera Therapeutics | 10.10B |
| Krystal Biotech | 9.98B |
| Summit Therapeutics | 9.92B |
| Ionis Pharmaceuticals | 9.76B |
| Protagonist Therapeutics | 9.75B |
| Spyre Therapeutics | 9.50B |